Literature DB >> 17805044

An Iranian child with HbQ-Iran [alpha75 (EF4) Asp-->His]/-alpha3.7 kb/IVSII.1 G-->A: first report.

Zohreh Rahimi1, Reza Akramipour, Asad Vaisi-Raygani, Ronald L Nagel, Adriana Muniz.   

Abstract

BACKGROUND: Hemoglobin Q (HbQ)-Iran [alpha75 (EF4) Asp-->His] is an alpha-chain variant that in the heterozygous state has normal hematology and has not been reported in association with a thalassemic phenotype. Here, for the first time, we described the hematologic characteristics of a 5-year-old boy with HbQ-Iran/-alpha3.7 kb trans to HbQ-Iran mutation/beta0-thalassemia (IVSII.1.G-->A) living in the Kermanshah province of Iran. OBSERVATIONS: The level of HbQ-Iran was found to be 22.4%. However, a significant reduction in mean corpuscular volume (59.3 fL) and mean corpuscular hemoglobin (19.6 pg) and an elevation of hemoglobin F (6.3%) was observed.
CONCLUSIONS: This report indicates that HbQ-Iran to be a benign structural variant of Hb, that in combination with -alpha3.7 kb gene and beta0-thalassemia, presents a minor beta-thalassemia picture with moderate anemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805044     DOI: 10.1097/MPH.0b013e318142b572

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  Hemoglobin Q-Iran detected in family members from Northern Iran: a case report.

Authors:  Mohammad Khorshidi; Payam Roshan; Nooshin Bayat; Mohammad Reza Mahdavi; Hossein Najmabadi
Journal:  J Med Case Rep       Date:  2012-02-06

Review 2.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

3.  HbD Punjab/HbQ India Compound Heterozygosity: An Unusual Association.

Authors:  Stacy Colaco; Reema Surve; Pratibha Sawant; Anita Nadkarni; Kanjaksha Ghosh; Roshan Colah
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

Review 4.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.